One Center • One Focus • One Team

tamoxifen

Tag:tamoxifen

2012 San Antonio Breast Cancer Symposium – Redondo Beach Talk

Cancer Support Community – Redondo Beach to Host Talk with Breast Cancer Updates from the 2012 San Antonio Breast Cancer Symposium 

Breastlink Breast Oncologist Dr. James Waisman to Share Insights from the Convention

Redondo Beach, Calif., January 8, 2013 – The Cancer Support Community – Redondo Beach (CSC-RB) announced James Waisman, M.D., a breast dedicated medical oncologist with Breastlink Medical Group, a network of comprehensive breast health centers, will provide a free, public talk covering key findings from the 2012 San Antonio Breast Cancer Symposium (SABCS). Dr. Waisman attended the 2012 SABCS, which was held December 4-8, 2012 in San Antonio.

“San Antonio is the largest and most important meeting on […]

By | January 9, 2013|Categories: Press Releases|Tags: , |0 Comments

San Antonio Breast Cancer Symposium 2012 – Tamoxifen

  • Although there were many meaningful announcements from the first two days of this year’s San Antonio Breast Cancer Symposium the release of a major study on adjuvant tamoxifen treatment was perhaps the most important.
  • The tamoxifen study, which gathered information from more than 6,800 women with estrogen receptor positive (ER+) breast cancer, showed a significant reduction in the reoccurrence of breast cancer.
  • This could be a noteworthy step to augment our ability to improve breast cancer survivorship – roughly 75% of breast cancers are ER+.

Background on Tamoxifen

Although tamoxifen was originally discovered in the 1960’s the US Food and Drug Administration (FDA) didn’t approve tamoxifen for the treatment […]

By | December 5, 2012|Categories: Cancer Research, Oncology|Tags: , |0 Comments
Load More Posts